IGCL - Indogulf Cropsci
📢 Recent Corporate Announcements
Indogulf Cropsciences Limited (IGCL) has submitted its Reconciliation of Share Capital Audit Report for the quarter ended March 31, 2026. The report confirms that the company's total issued and listed capital remains unchanged at 6,32,23,997 shares. Notably, 100% of the share capital is held in dematerialized form, with 84.40% in NSDL and 15.60% in CDSL. The company reported a total shareholder base of 24,093 at the end of the period.
- Total issued and listed capital stands at 6,32,23,997 equity shares with a face value of ₹10 each.
- 100% of the share capital is dematerialized, with zero shares held in physical form.
- NSDL holds the majority of shares at 84.40% (5,33,57,999 shares), while CDSL holds 15.60% (98,65,998 shares).
- The total number of shareholders as of March 31, 2026, is 24,093.
- No changes occurred in the share capital through rights, bonus, or other issues during the quarter.
Indogulf Cropsciences Limited (IGCL) has filed a formal declaration under SEBI (SAST) Regulations confirming that its promoters have not encumbered any of their shareholding during the financial year 2025-26. The disclosure, made by Mr. Om Prakash Aggarwal on behalf of the promoter group, confirms that no shares were pledged directly or indirectly. This annual compliance filing provides transparency regarding the financial health of the promoters and ensures that their equity remains free of liens. Such disclosures are standard but vital for maintaining investor confidence in the stability of the promoter's stake.
- Promoters declared zero encumbrance on their shareholding for the entire financial year 2025-26.
- The declaration covers four key promoter group members: Om Prakash, Sanjay, Anshu, and Arnav Aggarwal.
- Compliance was met under Regulation 31(4) and 31(5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
- The filing was submitted to both BSE and NSE on April 09, 2026.
Indogulf Cropsciences Limited (IGCL) has successfully submitted its Reconciliation of Share Capital Audit Report for the quarter ended March 31, 2026. The report confirms that the company's total issued and listed capital remains unchanged at 6,32,23,997 shares. Notably, the company has achieved 100% dematerialization of its shares, with 84.40% held in NSDL and 15.60% in CDSL. As of the quarter end, the company maintains a shareholder base of 24,093 investors.
- Total issued and listed capital stands at 6,32,23,997 equity shares with a face value of ₹10 each.
- 100% of the share capital is held in dematerialized form, with zero physical shares outstanding.
- NSDL holds the majority share of demat holdings at 84.40% (5,33,57,999 shares).
- The total number of shareholders as of March 31, 2026, is reported at 24,093.
- No changes in share capital, such as rights issues or bonus issues, occurred during the quarter.
Indogulf Cropsciences Limited (IGCL) has announced the successful passage of four key resolutions via postal ballot. Shareholders overwhelmingly approved the re-appointment of Mr. Om Prakash Aggarwal as Executive Chairman and Mr. Sanjay Aggarwal as Managing Director, both with 99.98% of valid votes. Additionally, two Independent Directors were re-appointed with similar margins. The high voter turnout, representing approximately 75.94% of the total paid-up capital, reflects strong shareholder confidence in the current leadership.
- Re-appointment of Om Prakash Aggarwal as Executive Chairman approved with 99.98% of valid votes.
- Sanjay Aggarwal re-appointed as Managing Director with 99.98% shareholder approval.
- Total voter turnout represented approximately 75.94% of the company's total paid-up capital of 6,32,23,997 shares.
- Two Independent Directors, Rahul Gupta and Sandeep Bhutani, were also re-appointed with 99.98% majority.
Indogulf Cropsciences Limited (IGCL) has announced the closure of its trading window effective April 1, 2026, in compliance with SEBI Insider Trading regulations. This closure is ahead of the board's consideration and approval of the audited financial results for the quarter and full financial year ending March 31, 2026. The restriction applies to all designated persons, including directors and key management personnel, until 48 hours after the results are declared. This is a standard regulatory procedure and does not indicate any underlying operational change.
- Trading window closure begins on April 1, 2026.
- Closure is for the purpose of approving audited financial results for Q4 and FY ending March 31, 2026.
- Restriction applies to employees, directors, and designated persons as per SEBI regulations.
- The window will reopen 48 hours after the financial results are made public.
Indogulf Cropsciences Limited (IGCL) has announced the appointment of M/s Adfactors PR Private Limited as its Investor Relations agency. The engagement is scheduled to commence on April 01, 2026, to manage communications between the company and the investment community. The agreement involves no shareholding by the agency in IGCL and grants no special rights such as board seats or capital structure restrictions. This move is part of the company's efforts to streamline investor outreach and regulatory compliance.
- Appointment of M/s Adfactors PR Private Limited as the official Investor Relations agency.
- The engagement becomes effective starting April 01, 2026.
- Adfactors PR holds NIL shareholding in Indogulf Cropsciences Limited.
- The agreement is at arm's length with no related party involvement or special rights granted.
Indogulf Cropsciences Limited (IGCL) has announced the resignation of Mr. Deepak Rawat from the position of Secretarial Auditor, effective March 17, 2026. The resignation is attributed to health issues and medical reasons, rather than any professional disagreements or material concerns regarding the company's operations. The auditor has explicitly confirmed that there are no other material reasons for his departure. The company will now need to appoint a new Secretarial Auditor to fulfill its statutory compliance obligations.
- Mr. Deepak Rawat resigned as Secretarial Auditor effective March 17, 2026.
- The resignation is cited as being due to health issues and other medical reasons.
- The auditor confirmed no material reasons for resignation exist other than health concerns.
- Disclosure made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations.
Indogulf Cropsciences Limited (IGCL) has informed the exchanges about the resignation of Mr. Deepak Rawat as the Secretarial Auditor of the company, effective March 17, 2026. The resignation is attributed to health issues and medical reasons, with the auditor confirming there are no other material reasons for his departure. This disclosure follows Regulation 30 of the SEBI Listing Regulations. The company will now need to appoint a new Secretarial Auditor to maintain its statutory compliance framework.
- Mr. Deepak Rawat (ACS: 33210) resigned as Secretarial Auditor effective March 17, 2026.
- The resignation is based on health issues and medical reasons rather than any professional dispute.
- The auditor explicitly confirmed that there are no other material reasons for the resignation.
- The company complied with SEBI Master Circular dated November 11, 2024, for the disclosure.
Indogulf Cropsciences Limited (IGCL) has issued a postal ballot notice to seek shareholder approval for the re-appointment of its top leadership for five-year terms. The company proposes extending the tenures of Executive Chairman Om Prakash Aggarwal and Managing Director Sanjay Aggarwal starting April 1, 2026. Additionally, two Independent Directors, Rahul Gupta and Sandeep Bhutani, are proposed for their second five-year terms. Shareholders can cast their votes via e-voting between February 27 and March 28, 2026.
- Proposed 5-year re-appointment of Om Prakash Aggarwal as Executive Chairman starting April 1, 2026.
- Proposed 5-year re-appointment of Sanjay Aggarwal as Managing Director starting April 1, 2026.
- Re-appointment of Independent Directors Rahul Gupta and Sandeep Bhutani for second 5-year terms.
- E-voting period scheduled from February 27, 2026, to March 28, 2026.
- Cut-off date for voting eligibility established as February 20, 2026.
Indogulf Cropsciences (IGCL) has entered into a Memorandum of Agreement with the Confederation of Indian Industry (CII) and ICAR-IARI to implement the Prime Minister’s Fellowship for Doctoral Research. Under this agreement, the company will support a full-time PhD scholar for a four-year period from January 1, 2026, to December 31, 2029. The research will focus on high-impact areas such as bio-stimulants for drought and heat stress, abiotic stress tolerance, and genome editing. This strategic collaboration is designed to enhance the company's R&D pipeline and foster industry-relevant innovation in the agri-input sector.
- Execution of MoA with CII and ICAR-IARI for the Prime Minister’s Fellowship for Doctoral Research.
- Commitment to support a PhD scholar for a maximum period of 4 years (2026-2029).
- Research focus on climate change mitigation strategies including bio-stimulants and genome editing.
- Collaboration aims to strengthen academia-industry ties and develop next-generation agricultural talent.
- Indogulf operates in 34+ countries with manufacturing facilities in Haryana and Jammu & Kashmir.
Indogulf Cropsciences reported a resilient Q3 FY26 with revenue growing 17% YoY to INR 116.1 crore, despite a challenging operating environment and subdued crop prices. For the 9M FY26 period, the company achieved a robust 31% growth in PAT to INR 28 crore, driven by strong performance in the B2B segment (up 26%) and plant nutrition (up 23%). The subsidiary AGPL contributed INR 54 crore in sales during the first nine months, showing successful integration and market acceptance. Management highlighted new export orders from Venezuela, Taiwan, and Sudan worth INR 4-5 crore, expected to boost Q4 performance.
- Q3 FY26 Revenue increased 17% YoY to INR 116.1 crore, while EBITDA rose 16% to INR 11.7 crore.
- 9M FY26 PAT grew by 31% YoY to INR 28 crore, supported by a 19.3% increase in total revenue to INR 553 crore.
- B2B segment outperformed with 26% YoY growth, while the Plant Nutrition vertical grew by 23% in the 9M period.
- Subsidiary AGPL achieved gross sales of INR 54 crore in 9M FY26, contributing significantly to overall margins.
- Secured initial export orders worth INR 4-5 crore from new markets including Venezuela, Taiwan, and Sudan for Q4 execution.
Indogulf Cropsciences Limited (IGCL) has officially released the audio recording of its earnings conference call held on February 12, 2026. The call was conducted to discuss the company's financial and operational performance for the third quarter of FY25-26. This disclosure is a routine regulatory requirement under SEBI (LODR) Regulations, 2015, aimed at maintaining transparency with shareholders. Investors can access the recording via the link provided in the exchange filing to understand management's perspective on recent results.
- Earnings conference call for Q3 FY25-26 results held on February 12, 2026.
- Audio recording link made available to the public via BSE and NSE filings.
- Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- Provides a platform for investors to hear management's detailed commentary on business growth.
Indogulf Cropsciences (IGCL) reported a resilient Q3FY26 with revenue growing 17% YoY to ₹1,161 Mn and EBITDA rising 16.4% to ₹117 Mn. While Profit Before Tax (PBT) surged 60.2% to ₹74 Mn, Profit After Tax (PAT) saw a more modest growth of 5.6% YoY at ₹39 Mn for the quarter. The nine-month (9M) performance remains robust, with PAT increasing 31.1% YoY to ₹284 Mn. The company also announced a strategic entry into the Venezuela market, with initial orders expected to be executed in Q4 FY26.
- Q3 Revenue from operations increased 17% YoY to ₹1,161 Mn.
- 9M FY26 Profit After Tax (PAT) grew significantly by 31.1% YoY to ₹284 Mn.
- Profit Before Tax (PBT) for Q3 surged 60.2% YoY to ₹74 Mn from ₹46 Mn.
- EBITDA for 9M FY26 increased 23.5% YoY to ₹536 Mn, indicating improved operational efficiency.
- Entered the Venezuela market with initial orders slated for execution in the upcoming quarter (Q4 FY26).
Indogulf Cropsciences reported a resilient Q3 FY26 with revenue growing 17% YoY to ₹1,161 million, driven by strong performance in B2B and B2C segments. Despite a challenging environment with subdued crop prices, the company achieved a 60% YoY growth in PBT to ₹74 million. For the 9M FY26 period, revenue and EBITDA grew by 19% and 23% respectively, supported by a 21% revenue contribution from new product launches. The company is expanding its global footprint, recently entering Venezuela and Taiwan, and is utilizing IPO proceeds for debt reduction and a new dry flowable plant.
- Q3 FY26 revenue increased 17% YoY to ₹1,161 million, while 9M FY26 revenue rose 19% to ₹5,538 million.
- PBT for Q3 FY26 saw a significant jump of 60% YoY to ₹74 million, reflecting improved operational efficiencies.
- New products launched in the last 3 years contributed 21% to the 9M FY26 revenue, highlighting R&D success.
- International expansion continues with 34+ countries reached and new market entries in Venezuela and Taiwan.
- Utilization of ₹1,600 million IPO proceeds is underway for debt reduction and setting up a new dry flowable plant in Haryana.
Indogulf Cropsciences (IGCL) reported a 10.4% YoY revenue growth in Q3 FY26, reaching ₹1,085.81 million. Net profit for the quarter improved to ₹54.88 million from ₹45.76 million in the same period last year. The board has approved the re-appointment of the Executive Chairman and Managing Director for five-year terms, ensuring leadership stability. For the nine-month period, revenue grew to ₹5,400.09 million, reflecting a healthy upward trajectory compared to the previous year.
- Revenue from operations grew 10.4% YoY to ₹1,085.81 million in Q3 FY26.
- Net profit for Q3 FY26 increased to ₹54.88 million compared to ₹45.76 million in Q3 FY25.
- 9M FY26 revenue stands at ₹5,400.09 million, up from ₹4,694.57 million YoY.
- Executive Chairman and Managing Director re-appointed for 5-year terms effective April 2026.
- Internal Auditor M/s Aditi Gupta & Associates appointed for FY 2025-26.
Financial Performance
Revenue Growth by Segment
In H1 FY26, B2B Domestic revenue grew 23.6% to INR 1,863 million, B2C Domestic revenue grew 19% to INR 2,320 million, and Exports grew 6.4% to INR 334 million. Total H1 FY26 revenue reached INR 4,377 million, a 20% YoY increase.
Geographic Revenue Split
The company saw significant growth in H1 FY26 across key Indian states: Haryana (+60%), Maharashtra (+26%), Uttar Pradesh (+25%), and Andhra Pradesh (+22%). Exports currently contribute approximately 7.6% of H1 FY26 revenue.
Profitability Margins
Gross margins improved to 26.2% in H1 FY26 from 24.3% in H1 FY25. PAT margins increased to 7.3% in H1 FY26 compared to 6.8% in H1 FY25, driven by higher B2C sales and better operating leverage.
EBITDA Margin
EBITDA margin for H1 FY26 stood at 9.6%, up from 9.1% YoY. Q2 FY26 EBITDA margin was significantly higher at 12.9% (INR 320 million) due to seasonal peak demand for B2C products like Orion Gold.
Capital Expenditure
The company is investing INR 70 crore in a new formulation plant at Sonipat to increase capacity by 50% and INR 14 crore for a new Dry Flowable (DF) unit, both expected to commence operations in Q1 FY2027.
Credit Rating & Borrowing
Credit rating was upgraded in Q2 FY26 to [ICRA]A- (Stable) and [ICRA]A1. Interest coverage ratio was 4.4x in FY2025, with debt/equity improving to 0.5x post-IPO debt repayment.
Operational Drivers
Raw Materials
Technicals and chemical intermediates for pesticides and fertilizers; imports account for 25-30% of total raw material requirements.
Import Sources
Approximately 25-30% of raw materials are imported from international markets to support the technical and formulation units.
Capacity Expansion
Current operations span 4 manufacturing units across 20 acres. Planned expansion at Sonipat will add 50% to existing formulation capacity by Q1 FY2027 to meet growing domestic demand.
Raw Material Costs
Raw material costs are subject to volatility in global commodity prices and forex rates; the company is pursuing backward integration into technical manufacturing to secure supply and expand margins.
Manufacturing Efficiency
The company is implementing SAP and automation to streamline operations and leverage economies of scale as it expands production capacity.
Logistics & Distribution
The company utilizes a wide distribution network for its B2C segment, with a specific focus on increasing the dealer presence of its subsidiary Abhiprakash Globus Private Limited (AGPL).
Strategic Growth
Expected Growth Rate
20%
Growth Strategy
Growth will be driven by a 50% capacity expansion at the Sonipat plant by FY2027, the launch of 12 new products in H1 FY26 which already contribute 3% to revenue, and a multi-brand strategy where the Mascot Giraffe brand (AGPL) now contributes 9% of revenue.
Products & Services
Insecticides, fungicides, herbicides, plant growth regulators, crop nutrients, and biologicals.
Brand Portfolio
Orion Gold, Mascot Giraffe (under subsidiary AGPL).
New Products/Services
12 new products launched in H1 FY26 across categories, contributing 3% to Q2 FY26 revenues.
Market Expansion
Expanding B2C presence in high-growth states like Haryana and Maharashtra and increasing penetration in European export markets.
Strategic Alliances
Maintains long-term relationships with international technical manufacturers for raw material sourcing.
External Factors
Industry Trends
The industry is growing but faces disruption from bio-products and stricter environmental safety norms. IGCL is positioning itself by expanding its 'Biologicals' segment, which grew to INR 209 million in H1 FY26.
Competitive Landscape
Intense competition from both domestic players and multinational corporations in the fragmented agrochemical space.
Competitive Moat
Sustainable advantages include 30+ years of promoter experience, a massive portfolio of 300+ registered products, and an established B2C dealer network that creates high entry barriers.
Macro Economic Sensitivity
Highly sensitive to agro-climatic conditions (monsoon) and government agricultural policies.
Consumer Behavior
Farmers are increasingly shifting toward bio-stimulants and safer product formulations due to evolving safety policies.
Geopolitical Risks
Trade barriers or regulatory changes in Europe could impact the company's export growth strategy.
Regulatory & Governance
Industry Regulations
The Government of India banned 4 pesticides (Dicofol, Dinocap, Methomyl, Monocrotophos) in Oct 2023; 24 more remain under regulatory review, creating potential portfolio risk.
Environmental Compliance
The company must comply with mandatory safety norms for product packaging, storage, and transportation; no specific ESG cost figure provided.
Risk Analysis
Key Uncertainties
Vulnerability to erratic monsoons (impacted Q2 growth by 13% vs guidance) and potential further pesticide bans by the government.
Geographic Concentration Risk
Significant revenue concentration in Northern and Western India, specifically Haryana and Maharashtra.
Third Party Dependencies
Reliance on international suppliers for 25-30% of raw material technicals.
Technology Obsolescence Risk
Risk of pest resistance to existing chemical formulations, requiring constant R&D and new product launches.
Credit & Counterparty Risk
Receivables remain elevated due to the credit-extended nature of the agricultural distribution channel.